Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
162
datasets available to search
ShareScore release 0.9.0
Dataset results
162 results for “HDAC inhibitors”
Dietary Histone Deacetylase Inhibitors (HDAC)
ClinicalTrials.gov study NCT01543074. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
ClinicalTrials.gov study NCT01680094. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)
ClinicalTrials.gov study NCT00773838. IPD Sharing: YES. Countries: 0. Publications: 1.
HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon Cancer
ClinicalTrials.gov study NCT06709885. IPD Sharing: NO. Countries: 1. Publications: 15.
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
ClinicalTrials.gov study NCT02836548. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02569320. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov study NCT03565406. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
ClinicalTrials.gov study NCT00127101. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Data from: Nɛ-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors
HDAC inhibitors have been developed very rapidly in clinical trials and even in approvals for treating several cancers. However, there are few reported HDAC inhibitors designed from Nε-acetyl lysine. In current study, we raised a novel design, which is about Nε-acetyl lysine analogues containing amide acetyl groups with the hybridization of ZBG groups as novel HDAC inhibitors.
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
ClinicalTrials.gov study NCT00606307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
ClinicalTrials.gov study NCT02032810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Nɛ-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors
Open the record for dataset details and reuse information.
Mouse embryonic kidneys (E13.5): HDAC inhibitor (HDACi) treated vs. Control
GEO Series GSE19581. Mus musculus. 6 samples. Type: Expression profiling by array.
HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors
GEO Series GSE81380. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
Aberrant JAK-STAT pathway confers resistance to the HDAC inhibitor chidamide in Natural Killer/T-cell lymphoma through chromatin remodeling
GEO Series GSE152185. Homo sapiens. 25 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing.
The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intra-cellular communication after learning [scRNA-seq]
GEO Series GSE185454. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intra-cellular communication after learning
GEO Series GSE185455. Mus musculus. 62 samples. Type: Expression profiling by high throughput sequencing.
Selective Class IIa HDAC inhibitor alters gene expression in NRVMs
GEO Series GSE130150. Rattus norvegicus. 4 samples. Type: Expression profiling by high throughput sequencing.
Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC inhibitors
GEO Series GSE85853. Homo sapiens. 126 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Genome-wide transcriptional, epigenetic, and topological changes occurring in human natural killer cells in response to HDAC inhibitor [ChIP-seq]
GEO Series GSE227660. Homo sapiens. 9 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.